Mylan.co.uk Information

Mylan ranks among the leading global generic and specialty pharmaceutical companies. Ranked number 3 in the UK generic prescription market, Mylan maintains one of the industrys broadest and highest quality portfolios, with around 1,400 high quality generic, branded and over-the-counter products globally, covering most available dosage forms and a big range of therapeutic categories. At Mylan we have one global quality standard in everything we do. Our internal teams conduct reviews of all products, start to finish. No matter where in the world they are made. Why such high standards? Because we truly care about the people who will be helped by the medicines we make. And we believe in earning that trust from physicians, pharmacists, other health care professionals and patients, every day. Its why we say, Our Mylan is Your Mylan. Want to know more about generic medicines? See the facts, figures, and bioequivalence details below. Generic products have a 67% market share in the UK, with generic prices in the UK the lowest in the developed world and constrained by free market competition1 The UK Medicines and Healthcare Products Regulatory Agency (MHRA) and/or the European Medicines Agency (EMA), assess quality, safety and efficacy and approve every medicine before it can be sold in the UK To gain MHRA and EMA approval, generic medicines must be proven to be bioequivalent to their brand name counterparts. That means generic and brand name medicines are essentially the same in the following ways: